Starling Oncology, Inc. Deferred Revenue Recognized
Starling Oncology, Inc. (DFPH) reported Deferred Revenue Recognized of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2025-11-13
- Starling Oncology, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. contract with customer, liability, revenue recognized for the quarter ending 2024-09-30 was $718.00K.
- Starling Oncology, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $594.00K, a 170.00% increase from fiscal 2022.
- Starling Oncology, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $220.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | ||||
| 2024-09-30 | $718.00K 10-Q · filed 2025-11-13 | $718.00K 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $489.00K 10-Q · filed 2025-08-13 | $489.00K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $545.00K 10-Q · filed 2025-05-14 | $0.00 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | $594.00K 10-K · filed 2024-03-28 | ||||
| 2023-06-30 | $529.00K 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | $264.00K 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | $220.00K 10-K · filed 2024-03-28 |